Research with human participants

Overview of medical research in the Netherlands

The applicability of rapid serological and molecular testing for Corona SARS-2 in a Dutch population during the COVID-19 outbreak.

Published:
Last updated:

nvt

Download: PDF | XML
Ethical review
Not approved
Status
Will not start
Health condition type
Viral infectious disorders
Study type
Observational invasive

ID

NL-OMON49670

Source

ToetsingOnline

Brief title

Research performance point of care diagnostics Corona SARS-2

Condition

  • Viral infectious disorders

Synonym

Corona SARS-2, COVID-19

Research involving

Human

Sponsors and support

Primary sponsor :
Ministerie van Defensie
Source(s) of monetary or material Support :
Ministerie van Defensie

Intervention

Keyword :
COVID-19, Molecular diagnostics, Rapid test, Serology

Outcome measures

Primary outcome

nvt

Secondary outcome

nvt

Background summary

nvt

Study objective

nvt

Study design

nvt

Study burden and risks

nvt

Public
Ministerie van Defensie

Korte molenweg 3
Amsterdam 3941PW
NL
Scientific
Ministerie van Defensie

Korte molenweg 3
Amsterdam 3941PW
NL

Listed location countries

Netherlands

Age

Adults (18-64 years)
Elderly (65 years and older)

Inclusion criteria

zie onder

Exclusion criteria

zie onder

Design

Study type :
Observational invasive
Intervention model
:
Other
Allocation :
Non-randomized controlled trial
Masking :
Open (masking not used)
Control :
Active
Primary purpose :
Health services research

Recruitment

NL
Recruitment status
:
Will not start
Enrollment :
300
Type :
Anticipated

Not approved
Date :
Application type :
First submission
Review commission :
METC NedMec

Followed up by the following (possibly more current) registration

No registrations found.

Other (possibly less up-to-date) registrations in this register

No registrations found.

In other registers

Register ID
CCMO NL73721.041.20